Elan, Medtronic deal

ELN reacquired rights from Medtronic to ziconotide ( SNX-111), an N-type calcium channel blocker. Medtronic had acquired exclusive U.S. marketing rights from ELN's Neurex Corp. subsidiary (Menlo Pa...